Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests $101
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests $229
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical data sheet

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  3. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  4. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  5. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  6. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  7. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  8. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  9. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  10. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  11. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  12. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  13. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  14. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  15. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  16. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  17. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  18. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  19. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  20. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  21. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  22. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  23. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  24. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  25. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  26. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  27. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  28. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  29. Mair F, et al. 2022. Nature. 605:728. PubMed
  30. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  31. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  32. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  33. Campisi L, et al. 2022. Nature. 606:945. PubMed
  34. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  35. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  36. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  37. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  38. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  39. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  40. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  41. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  42. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  43. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  44. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  45. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  46. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  47. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  48. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  49. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  50. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  51. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  52. Sun W, et al. 2023. Nature. 614:309. PubMed
  53. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  54. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  55. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  56. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  57. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  58. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  59. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  60. Wang CQ, et al. 2023. Cells. 12: . PubMed
  61. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  62. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  63. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  64. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  65. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  66. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  67. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  68. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  69. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  70. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  71. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  72. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  73. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  74. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  75. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  76. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  77. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  78. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  79. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  80. Li S, et al. 2022. Nature. 610:373. PubMed
  81. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  82. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  83. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  84. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  85. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  86. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  87. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  88. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  89. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  90. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  91. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  92. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  93. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  94. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  95. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  96. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  97. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  98. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  99. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  100. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  101. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  102. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  103. Gao F, et al. 2023. Immunity. 56:864. PubMed
  104. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  105. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  106. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  107. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  108. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  109. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  110. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  111. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  112. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  113. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  114. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  115. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  116. Solier S, et al. 2023. Nature. 617:386. PubMed
  117. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  118. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  119. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  120. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  121. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  122. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  123. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  124. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  125. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  126. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  127. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  128. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  129. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  130. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  131. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  132. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  133. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  134. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  135. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  136. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  137. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  138. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  139. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  140. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  141. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  142. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  143. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  144. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  145. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  146. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  147. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  148. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  149. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  150. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  151. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  152. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  153. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  154. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  155. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  156. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  157. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  158. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  159. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  160. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  161. Jairaman A, et al. 2022. Elife. 11:. PubMed
  162. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  163. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  164. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  165. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  166. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  167. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  168. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  169. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  170. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  171. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  172. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  173. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  174. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  175. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  176. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  177. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  178. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  179. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  180. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  181. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  182. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  183. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  184. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  185. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  186. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  187. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  188. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  189. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  190. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  191. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  192. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  193. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  194. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  195. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  196. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  197. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  198. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  199. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  200. Ogbe A, et al. 2022. JCI Insight. . PubMed
  201. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  202. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  203. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  204. Woodruff MC, et al. 2022. Nature. :. PubMed
  205. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  206. Kumar V, et al. 2022. Cells. 11:. PubMed
  207. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  208. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  209. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  210. Vijayakumar B, et al. 2022. Immunity. . PubMed
  211. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  212. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  213. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  214. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  215. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  216. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  217. Dogra P, et al. 2020. Cell. 749:180. PubMed
  218. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  219. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  220. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  221. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  222. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  223. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  224. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  225. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  226. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  227. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  228. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  229. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  230. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  231. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  232. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  233. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  234. Kreutmair S, et al. 2021. Immunity. . PubMed
  235. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  236. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  237. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  238. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  239. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  240. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  241. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  242. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  243. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  244. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  245. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  246. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  247. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  248. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  249. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  250. Romine KA, et al. 2021. Cancer Discov. . PubMed
  251. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  252. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  253. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  254. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  255. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  256. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  257. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  258. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  259. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  260. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  261. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  262. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  263. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  264. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  265. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  266. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  267. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  268. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  269. Shi J, et al. 2014. Blood. 123:4015. PubMed
  270. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  271. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  272. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  273. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  274. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  275. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  276. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  277. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  278. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  279. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  280. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  281. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  282. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  283. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  284. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  285. Thijssen R, et al. 2022. Blood. :. PubMed
  286. Good Z, et al. 2022. Nat Med. :. PubMed
  287. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  288. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  289. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  290. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  291. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  292. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  293. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  294. Woodruff M, et al. 2020. medRxiv. . PubMed
  295. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  296. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  297. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  298. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  299. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  300. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  301. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  302. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  303. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  304. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  305. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  306. Burns JC, et al. 2020. eLife. 9:00. PubMed
  307. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  308. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  309. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  310. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  311. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  312. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  313. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  314. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  315. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  316. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  317. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  318. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  319. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  320. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  321. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  322. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  323. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  324. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  325. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  326. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  327. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  328. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  329. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  330. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  331. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  332. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  333. Wang J, et al. 2022. iScience. 25:103971. PubMed
  334. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  335. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  336. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  337. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  338. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  339. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  340. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  341. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  342. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  343. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  344. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  345. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  346. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  347. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  348. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  349. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  350. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  351. Song M, et al. 2018. Nature. 562:423. PubMed
  352. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  353. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  354. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  355. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  356. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  357. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  358. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  359. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  360. Feng W, et al. 2020. J Vis Exp. . PubMed
  361. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  362. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  363. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  364. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  365. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  366. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  367. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  368. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  369. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  370. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  371. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  372. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  373. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  374. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  375. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  376. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  377. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  378. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  379. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  380. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  381. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  382. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  383. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  384. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  385. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  386. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  387. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  388. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  389. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  390. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  391. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  392. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  393. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  394. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  395. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  396. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  397. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  398. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  399. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  400. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  401. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  402. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  403. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  404. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  405. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  406. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  407. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  408. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  409. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  410. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  411. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  412. Georg P, et al. 2022. Cell. 185:493. PubMed
  413. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  414. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  415. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  416. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  417. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  418. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  419. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  420. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  421. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  422. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  423. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  424. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  425. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  426. Lederer K, et al. 2022. Cell. . PubMed
  427. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  428. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  429. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  430. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  431. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  432. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  433. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  434. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  435. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  436. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  437. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  438. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  439. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  440. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  441. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  442. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  443. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  444. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  445. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  446. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  447. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  448. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  449. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  450. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  451. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  452. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  453. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  454. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  455. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  456. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  457. Adamo S, et al. 2022. Nature. 602:148. PubMed
  458. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  459. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  460. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  461. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  462. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  463. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  464. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  465. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  466. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  467. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  468. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  469. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  470. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  471. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  472. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  473. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  474. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  475. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  476. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  477. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  478. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  479. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  480. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  481. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  482. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  483. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  484. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  485. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  486. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  487. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  488. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  489. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  490. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  491. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  492. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  493. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  494. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  495. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  496. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  497. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  498. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  499. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  500. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  501. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  502. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  503. Chen C, et al. 2022. iScience. 25:103645. PubMed
  504. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  505. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  506. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  507. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  508. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  509. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  510. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  511. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  512. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  513. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  514. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  515. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  516. Wang EY, et al. 2021. Nature. 595:283. PubMed
  517. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  518. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  519. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  520. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  521. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  522. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  523. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  524. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  525. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  526. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  527. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  528. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  529. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account